Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare's board met on May 30, 2025, and approved the audited standalone and consolidated financial results for Q4 and the full financial year ended March 31, 2025. The board also appointed Ms. Krupalibahen Rajeshbhai Mehta as an Additional Non-Executive Independent Director for a 5-year term, effective May 30, 2025, subject to shareholder approval. Ms. Mehta holds no shares in the company, is not related to any director, KMP, or promoter, and has no directorships in other listed entities. The auditor's report on the financial results is a qualified report, with the company attaching the required statement on the impact of audit qualifications.
Routine governance update with a new independent director strengthening the board. The qualified audit opinion on FY25 results is a mild concern that shareholders should review carefully, as it may indicate accounting or disclosure issues that could affect investor confidence.